Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
Elena Alexandrova, Annamaria Salvati, Giovanni Pecoraro, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts
Aleix Bayona‐Feliú, Emilia Herrera‐Moyano, Nibal Badra-Fajardo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Use of histone methyltransferase inhibitors in cancer treatment: A systematic review
Ludimila Leite Marzochi, Caroline Izak Cuzziol, Carlos Filho, et al.
European Journal of Pharmacology (2023) Vol. 944, pp. 175590-175590
Closed Access | Times Cited: 23
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
Chitra Thakur, Yiran Qiu, Yao Fu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 33
Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 16
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity
M. Honer, Benjamin Ferman, Zach H. Gray, et al.
Genes & Development (2024) Vol. 38, Iss. 11-12, pp. 473-503
Open Access | Times Cited: 7
Beyond the tail: the consequence of context in histone post-translational modification and chromatin research
Ellen N Weinzapfel, Karlie N. Fedder-Semmes, Zu‐Wen Sun, et al.
Biochemical Journal (2024) Vol. 481, Iss. 4, pp. 219-244
Open Access | Times Cited: 6
Research progress and applications of epigenetic biomarkers in cancer
Jianjun Gao, Wujiang Shi, Jiangang Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Cancer plasticity: Investigating the causes for this agility
Shubhraneel Saha, Nikita Pradhan, B Neha, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 138-156
Open Access | Times Cited: 16
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer
Annamaria Salvati, Viola Melone, Assunta Sellitto, et al.
Breast Cancer Research (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer
Zehui Tan, Ning Guo, Zhi Cao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3605-3623
Open Access | Times Cited: 2
Menin in Cancer
Ariana D. Majer, Xianxin Hua, Bryson W. Katona
Genes (2024) Vol. 15, Iss. 9, pp. 1231-1231
Open Access | Times Cited: 2
Diverse modes of regulating methyltransferase activity by histone ubiquitination
James K. Fields, Chad W. Hicks, Cynthia Wolberger
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102649-102649
Open Access | Times Cited: 6
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
Elena Alexandrova, Jessica Lamberti, Domenico Memoli, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat
Varvara Maksimova, Julia Makus, Valeriia Popova, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 7, pp. 968-978
Open Access | Times Cited: 5
Tumor-suppressive functions of protein lysine methyltransferases
Nur Aziz, Yo Han Hong, Han Gyung Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 12, pp. 2475-2497
Open Access | Times Cited: 5
The methyltransferase N6AMT1 participates in the cell cycle by regulating cyclin E levels
Margit Mutso, Baiba Brūmele, Evgeniia Serova, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298884-e0298884
Open Access | Times Cited: 1
An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation
Aditi Srivastava, Rumana Ahmad, Kusum Yadav, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112232-112232
Closed Access | Times Cited: 1
DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
Yaqi Zhang, Yinu Wang, Andres Felipe Valdivia, et al.
Molecular Cancer Research (2022) Vol. 21, Iss. 2, pp. 140-154
Open Access | Times Cited: 5
Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival
Jun Cui, Joseph Carey, Renee A. Reijo Pera
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 5
Epigenetic Alterations as an Adaptive Response to Chemotherapy
Rubiada, Kaneez Fatima, Iqra Mushtaq, et al.
(2024), pp. 215-241
Closed Access
Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HATs as anti-leukemia agents
Bidyadhar Sethy, Zih-Yao Yu, Iin Narwanti, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107771-107771
Closed Access
DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1
Justin Leung, Kyle M. Miller
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 11, pp. 955-957
Closed Access
Histone lysine methylation modifiers controlled by protein stability
Sungryul Park, Jin Hwa Cho, Jeong‐Hoon Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 10, pp. 2127-2144
Open Access
Antitumor Activity of Selenopsammaplin A Analog (SPA-10091-HCl) via Histone Methyltransferase DOT1L Degradation and Apoptosis Induction in Castration-Resistant Prostate Cancer Cells
Jaeho Han, Sehun Yang, Woong Sub Byun, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106991-106991
Open Access
Transcriptional dysregulation and insights into clinical implications in melanoma
Chen Shen, Mengjiao Chen, Xuanbingning Nian, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top